A research team led by Professor Lee Sang-chul of the Department of Urology at Seoul National University Bundang Hospital ...

No one wants to be diagnosed with or go through the physical and psychological toll of cancer. Which is why, sometimes, it's ...

A new review was published in Volume 16 of Oncotarget on June 17, 2025, titled "Optimizing enfortumab vedotin plus pembrolizumab therapy." ...

Bladder cancer, often misunderstood, affects both men and women, not just the elderly. While smoking is a significant risk ...

In a multi-institutional study published in Science Direct, researchers revealed that testing urine-based tumor DNA (utDNA) ...

Boston: TOBY, Inc., a biotech startup advancing non-invasive cancer detection through urine-based volatilomics and Artificial ...

A new urine-based tumor DNA (utDNA) test shows promise in predicting treatment response and recurrence risk, helping ...

A new cancer detection test to analyze volatile organic compounds through urine analysis, was granted the Breakthrough Device Designation status by the U.S. FDA. The system, which is built on gas ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

Bladder Cancer is a disease where cancer cells form in the tissues of the bladder. More common in males than females over 55 ...

CAR-T therapy targeting TM4SF1 in aggressive bladder cancer (HV) histologic variant , offering hope for treatment-resistant ...